Product Information

OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB is a generic product labeled by Accord Healthcare Inc., priced at $0.2343 per EA under NDC 16729036815. Its NADAC has been published 293 times since Oct 14, 2020.

FDA first approved this application on Feb 7, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB has been published 293 times since Oct 14, 2020, and over the history we have for it it has declined 70.9%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.